Eam Investors, LLC Opti Nose, Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.43 - $4.01 $245,896 - $287,476	71,690 Added 26.97%	337,513 $1.24 Million
Q2 2022 Aug 12, 2022	BUY	$1.76 - $3.82 $467,848 - $1.02 Million	265,823 New	265,823 $973,000
Q3 2018 Nov 08, 2018	SELL	$12.43 - $29.76 $480,742 - $1.15 Million	-38,676 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$18.75 - $28.46 $725,175 - $1.1 Million	38,676 New	38,676 $1.08 Million

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $40M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.